Apotea AB (publ) (FRA:V30) Long-Term Debt: €0.0 Mil (As of Mar. 2026)


FRA:V30 Apotea AB (publ) FRA:V30
19 GF Score
Price €6.84
! 1 Warning Sign
View Full Analysis

What is Apotea AB (publ) Long-Term Debt?

Apotea AB (publ) FRA:V30 +1.33% 19 Long-Term Debt is €0.0 Mil as of Mar. 2026. GuruFocus rates FRA:V30 with a GF Score™ of 19/100. The stock has 1 warning sign investors should review.

Apotea AB (publ)'s Long-Term Debt for the quarter that ended in Mar. 2026 was €0.0 Mil.


Apotea AB (publ)  (FRA:V30) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Apotea AB (publ) Long-Term Debt Related Terms


Apotea AB (publ) Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Apotea AB (publ)'s Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apotea AB (publ) Long-Term Debt Chart

Apotea AB (publ) Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
0.00 0.00 0.00 0.00 0.00

Apotea AB (publ) Quarterly Data
Dec21 Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:V30
19GF Score
Apotea AB (publ) FRA:V30
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of €0.0 Mil mean?
Apotea AB (publ) (FRA:V30) has a Long-Term Debt of €0.0 Mil as of Mar. 2026.
Is Apotea AB (publ)'s Long-Term Debt too high?
Apotea AB (publ)'s current Long-Term Debt is €0.0 Mil. Overall, Apotea AB (publ) has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s Long-Term Debt compare to competitors?
Apotea AB (publ)'s Long-Term Debt of €0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Apotea AB (publ)'s current Long-Term Debt is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (FRA:V30) has a current Long-Term Debt of €0.0 Mil. The current Long-Term Debt is €0.0 Mil. Apotea AB (publ)'s overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Apotea AB (publ) (FRA:V30), the current Long-Term Debt is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apotea AB (publ) Business Description

Other Exchanges APOTEA:SwedenV30:Germany
Address Sveavagen 168, Stockholm, SWE, 11346
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
19GF Score

Get the complete analysis for FRA:V30

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.84
Price